We are live on
!
Find out more
FBA
Front Barnett Associates Portfolio holdings
AUM
$833M
1-Year Est. Return
23.51%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+23.51%
3 Year Est. Return
+40.55%
5 Year Est. Return
+85.34%
10 Year Est. Return
+266.96%
AUM
$821M
AUM Growth
-$172M
(-17%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
45.68%
Holding
119
New
3
Increased
30
Reduced
43
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.44M |
| 2 |
Abbott
ABT
|
+$1.07M |
| 3 |
TransDigm Group
TDG
|
+$1.07M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$1.02M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$497K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.65M |
| 2 |
Estee Lauder
EL
|
+$3.35M |
| 3 |
Amphenol
APH
|
+$2.34M |
| 4 |
Danaher
DHR
|
+$2.18M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.41% |
| 2 | Industrials | 16.21% |
| 3 | Miscellaneous | 13.05% |
| 4 | Healthcare | 12.25% |
| 5 | Communication Services | 9.49% |
Similar funds
FDCC
MAM
IWP
DBT
CCA
FMAEN1
WWM
RWA
Front Barnett Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Front Barnett Associates held 119 positions worth $821M, down 17% from $994M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Front Barnett Associates's Q2 2022 filing shows 3 new, 30 increased, 43 reduced and 6 closed positions. Its largest new stake was TransDigm Group: 1,808 shares worth $970K. The largest sale was Thermo Fisher Scientific, an estimated $5.65M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Industrials and Miscellaneous.
- Front Barnett Associates's largest Q2 2022 buy was TransDigm Group: 1,808 shares worth $970K.
- Front Barnett Associates added most to AbbVie in Q2 2022, an estimated $1.44M increase.
- Front Barnett Associates's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $5.65M.
- Front Barnett Associates fully exited Fiserv Inc in Q2 2022, selling an estimated $277K.
- Front Barnett Associates's ten largest holdings make up 46% of its $821M portfolio in Q2 2022.
- Front Barnett Associates opened 3 new positions and closed 6 in Q2 2022.
- Front Barnett Associates's portfolio value fell 17% quarter-over-quarter to $821M.
Based on Front Barnett Associates's 13F filing for Q2 2022, filed 12 Aug 2022.